Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 10 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. US 7807645

    Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  2. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  3. US 7700547

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted

  4. US 7632510

    Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  5. US 7608261

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

  6. US 7601114

    Apparatus and method for enhancing tissue repair in mammals

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  7. CA 2708406

    COMPOSITION DE VACCIN ANTI-ALLERGIE POUR UNE ADMINISTRATION MUCOSALE

    ALK ABELLO AS [DK] · Granted Jul 16, 2009 · Expires Jul 11, 2029

    granted

  8. AU 2008340179

    Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Jul 2, 2009 · Expires Jun 27, 2029

    granted

  9. US 7534859

    Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted

  10. US 7531500

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted May 12, 2009 · Expires May 7, 2029

    granted

  11. US 7431931

    Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

  12. US 2008241252

    METHODS AND COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION TO TREAT OCULAR CONDITIONS

    ALLERGAN INC [US] · Granted Oct 2, 2008 · Expires Sep 27, 2028

    granted

  13. US 7427598

    Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted

  14. US 7387792

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Collegium Pharmaceutical, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted

  15. US 7358222

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  16. US 7354894

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  17. US 7335640

    Administration of hypocretin-1 for treatment of narcolepsy

    The Regents of the University of California · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

  18. US 7303748

    Method of treating eye injury with local administration of a VEGF inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

  19. US 7220757

    Compositions and methods for topical administration of 2-NH-heteroarylimidazoles

    Replidyne, Inc. · Granted May 22, 2007 · Expires May 17, 2027

    granted

  20. US 7198947

    Production of functional proteins: balance of shear stress and gravity

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Apr 3, 2007 · Expires Mar 29, 2027

    granted

  21. US 7179217

    Apparatus for enhancing tissue repair in mammals

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted

  22. US 7112341

    Pulmonary administration of dry powder formulations for treating infertility

    Nektar Therapeutics · Granted Sep 26, 2006 · Expires Sep 21, 2026

    granted

  23. US 7112566

    Systemic administration of Hypocretin-1

    The Regents of the University of California · Granted Sep 26, 2006 · Expires Sep 21, 2026

    granted

  24. US 7094045

    Microencapsulation system and method

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Aug 22, 2006 · Expires Aug 17, 2026

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.